Event details
Date
Time
Duration
Available On-Demand
The number of people living with diabetes is rising and is projected to increase sharply around the world. Diabetes is a significant global public health challenge, that when undiagnosed, or not adequately addressed, puts people at a higher risk of life-threatening complications, such as heart attack, kidney failure, liver disease, and more.
To aid in the diagnosis and monitoring of diabetes, a patient’s hemoglobin A1c (HbA1c) is recorded over a 2–3-month period as it measures the patient’s average blood glucose levels.
Key learning objectives
After attending this webinar, participants will be able to:
- Explain HbA1c testing and its correlation to historical diabetes patients' clinical outcomes studies
- Describe the HbA1c standardization process and the current state of HbA1c measurements
- Analyze potential analytical and biological interferences affecting HbA1c results
Accreditation statement
SelectScience is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. Attendees of this one-hour webinar are also entitled to 1.0 ACCENT Continuing Education Credits from the AACC. This activity was planned in accordance with ACCENT® Standards and Policies. Verification of Participation certificates are provided to registered participants based on completion of the activity, in its entirety, and the activity evaluation. For questions regarding continuing education, please email education@aacc.org.
Presenter
Dr. Randie Little
Research Professor in the Pathology and Anatomical Sciences department
University of Missouri School of Medicine
View BioRandie R. Little, Ph.D. is a Research Professor in the Pathology and Anatomical Sciences department at the University of Missouri School of Medicine and is the Director of the Diabetes Diagnostic Laboratory.
Dr. Little is the coordinator of the National Glycohemoglobin Standardization Program (NGSP network), a member of the NGSP Steering Committee and she coordinates the NIDDK C-peptide Standardization activities. Dr. Little is also the chair of the IFCC Insulin Standardization Work Group. Her recent publications include those on the effects of hemoglobin variants on HbA1c measurements, analytical goals for HbA1c measurement, and the standardization of C-peptide measurements.
Ellie studied biochemistry at the University of Nottingham, UK, and has previous experience working in management consultancy. As a member of the Editorial team, she now plays an integral role in shaping the content on SelectScience.